advertising
Link to jump to start of content The Seattle Times Company Jobs Autos Homes Rentals NWsource Classifieds seattletimes.com
The Seattle Times Business & Technology
Traffic | Weather | Your account Movies | Restaurants | Today's events

News, analysis and perspectives from the
technology team at The Seattle Times.
Have a news tip? Follow the links below to e-mail us.

All blogs and discussions:

Go

July 10, 2007

MediQuest Therapeutics Prepares To Seek FDA's Nod

Posted by Angel Gonzalez at 6:01 PM

Pharmaceutical start-up MediQuest Therapeutics, which specializes on topical treatments, is getting ready to seek regulatory approval of its first commercial treatment.

In late June, the privately held Bothell firm concluded its final clinical study of a therapy to treat Raynaud's disease, a disorder that makes the body's extremities overreact to cold temperatures.

MediQuest expects to file an application for the new treatment with the U.S. Food and Drug Administration "sometime before the end of the year," says Chief Executive Frederick Dechow. A new round of financing to underwrite the company's effort lies in the "not too distant future," he added.

The market for Raynaud's disease treaments could be in excess of $800 million a year, Dechow said. A successful venture round -- and product launch -- could mean up to 100 additional jobs, Dechow said. The company currently has 28 employees.

Share:    Digg     Newsvine

Tricia Duryee
Tricia Duryee
E-mail|Bio


Angel Gonzalez
Angel Gonzalez
E-mail|Bio


Kristi Heim
Kristi Heim
E-mail|Bio


Benjamin J. Romano
Benjamin J. Romano
E-mail|Bio


Mark Watanabe
Mark
Watanabe

E-mail|Bio

Marketplace

advertising

advertising